Core Viewpoint - The Chinese innovative pharmaceutical industry is transitioning from imitation to original innovation, with significant growth in outbound transactions and a promising future for internationalization [4] Group 1: Market Performance - As of May 29, 2025, the Sci-Tech Innovation Board 100 Index (000698) rose by 1.63%, with notable increases in constituent stocks such as Borui Pharmaceutical (688166) up 9.66% and Zhixiang Jintai (688443) up 6.57% [3] - The Sci-Tech 100 Index ETF (588030) increased by 1.60%, with a latest price of 0.95 yuan and a turnover rate of 1.16%, totaling 71.56 million yuan in transactions [3] - Over the past year, the average daily transaction volume of the Sci-Tech 100 Index ETF reached 424 million yuan, ranking first among comparable funds [3] Group 2: Fund Growth and Performance - The Sci-Tech 100 Index ETF saw a significant increase in scale, growing by 94.45 million yuan over the past two weeks, ranking second among comparable funds [4] - In the past week, the ETF's shares increased by 99 million, also ranking first among comparable funds [5] - The ETF has experienced a net inflow of 71.08 million yuan over the last five trading days, indicating strong investor interest [5] Group 3: Financial Metrics - As of May 28, 2025, the Sci-Tech 100 Index ETF's net value increased by 19.94% over the past year, with a maximum monthly return of 27.67% since inception [5] - The ETF's management fee is 0.15% and the custody fee is 0.05%, making it the lowest among comparable funds [5] - The tracking error for the ETF over the past six months is 0.016%, indicating high tracking precision compared to similar funds [5] Group 4: Industry Insights - From the beginning of 2025 to the present, the total outbound transaction amount for innovative drugs has reached 45.5 billion USD, with upfront payments totaling 2.2 billion USD, suggesting a record year ahead [4] - Most domestic innovative drugs currently in the U.S. are in clinical stages, with significant potential for future growth as they progress towards commercialization [4]

A股半导体企业密集宣布赴港上市或相关进展。 5月24日，韦尔股份（603501）公告，拟发行H股并在香港联交所主板上市。5月21日，兆易创新 （603986）同样宣布拟赴港上市。同日，紫光股份（000938）披露在股东大会上，通过了发行H股并于 香港联交所主板上市方案的议案…… 其次，不论采用Fabless还是IDM模式，在港搭建海外融资平台并推行业务出海计划，亦为A股半导体企 业赴港的重要因素。例如，作为Fabless芯片设计公司，韦尔股份认为，启动发行H股是根据公司总体发 展战略及运营需要，旨在加快公司的国际化战略及海外业务发展，增强公司的境外融资能力等。 杰华特采用虚拟IDM模式。据披露，公司本次H股募资计划用于：创新预研团队、丰富产品组合、完善 海外销售网络布局、战略性投资与收购、补充营运资金及一般企业用途等。 最后，"A+H"上市热度提升，还有着政策层面的持续支撑。今年4月，中国证监会发布五项资本市场对 港合作措施，其中第五项是支持内地行业龙头企业赴香港上市。 港交所行政总裁陈翊庭近期表示，目前已有逾40家A股公司宣布赴港上市或已递交上市申请，未来几个 月预计有更多A股公司来港上市。 据证券时报记者 ...

市场表现方面，已上市的4家公司均出现了不同程度的上涨，其中，吉宏股份首日涨幅超39%，恒瑞医药、钧达股份涨超20%，宁德时代涨超16%。 | H股状态 | 港股代码 | 证券名称 | 首日涨跌幅 | 上市日: | | --- | --- | --- | --- | --- | | 已上市 | 02603. HK | 吉宏股份 | 39.06% | 2025/5/: | | | 01276. HK | 恒瑞医药 | 25. 20% | 2025/5/: | | | 03750. НК | 宁德时代 | 16. 43% | 2025/5/: | | | 02865. HK | 钧达股份 | 20. 09% | 2025/5/ | | | 06693. HK | 赤峰黄金 | 0.00% | 2025/3/ | 数据来源：港交所，艾德一站通统计 香港财政司司长陈茂波表示，今年以来，香港新股集资额超过760亿港元，较去年同期增加超过七倍，并已达到去年全年新股集资总额近九成。 2025年开年以来，A股公司赴港上市进程显著提速。截至目前，已有5家企业成功登陆港股，较往年同期实现数量级增长。 当前，港交所"A+H"上市通道 ...

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 69.5, unchanged from previous assessments [2][10]. Core Insights - The company completed a placement of HKD 120 million on May 21, at a price of HKD 40 per share, to enhance upstream manufacturing capabilities and support general working capital [1][10]. - Revenue growth is projected to be between 27% and 33% from 2025 to 2027, with a gross margin expected to remain between 53% and 54% [2][10]. - The company’s stock price increased by 6.6% to HKD 47.6 as of May 21 [1]. Financial Summary - **Revenue Forecast**: - FY23A: RMB 464 million - FY24A: RMB 579 million - FY25E: RMB 770 million (33% YoY growth) - FY26E: RMB 1,006 million (30.8% YoY growth) - FY27E: RMB 1,284 million (27.6% YoY growth) [3][14] - **Gross Margin**: - FY23A: 55.4% - FY24A: 53.0% - FY25E: 53.8% - FY26E: 53.5% - FY27E: 53.3% [3][14] - **Net Profit Forecast**: - FY23A: RMB 109.2 million - FY24A: RMB 166.6 million - FY25E: RMB 216.7 million (30.1% YoY growth) - FY26E: RMB 285.1 million (31.5% YoY growth) - FY27E: RMB 363.3 million (27.4% YoY growth) [3][14] - **Earnings Per Share (EPS)**: - FY23A: RMB 2.42 - FY24A: RMB 2.78 - FY25E: RMB 3.61 - FY26E: RMB 4.75 - FY27E: RMB 6.05 [3][14] - **Valuation Metrics**: - FY25E P/E ratio: 12.9x - FY26E P/E ratio: 9.8x [10][12] Shareholder Structure - Major shareholders include Li Zhen with 53.5% and Zhang Guangping with 39.5% [6]. Market Performance - The company's market capitalization is approximately HKD 3,042 million, with a 52-week high of HKD 51.75 and a low of HKD 23.05 [5]. - The stock has shown significant performance, with a 59.4% return over the past three months [7].

Core Viewpoint - The recent shareholding activities of Suzhou Naxin Microelectronics Co., Ltd. indicate a strategic response to financial needs and market conditions, with significant shareholder reductions and transfers occurring in a short timeframe [2][3][7][9]. Group 1: Shareholder Actions - On May 20, 2023, Naxin Micro announced the completion of a shareholder reduction plan, involving multiple shareholders including Guorun Ruqi and Shenzhen Huiyue Growth Investment Fund, with total shares reduced amounting to 1,424,462 shares at prices ranging from 136.26 to 185.50 CNY per share, totaling approximately 227.84 million CNY [2][3]. - Following this, on May 21, 2023, the company initiated a share transfer plan involving 4.85 million shares, representing 3.40% of the total share capital, primarily due to funding needs of the actual controlling entities [7][8]. - The inquiry transfer on May 27, 2023, resulted in a successful subscription of the shares at a price of 163.15 CNY per share, with a total of 4,851,800 shares transferred to six institutional investors, reducing the controlling entities' shareholding from 34.76% to 31.11% [7][8]. Group 2: Company Performance - Naxin Micro's financial performance has shown volatility, with a 93.76% increase in revenue in 2022, but a subsequent 21.52% decline in 2023, resulting in a net loss of 305 million CNY [9]. - Despite a projected revenue increase of 49.53% in 2024, the company is still facing losses, with a net loss of 403 million CNY anticipated [9]. - The first quarter of 2025 showed a revenue increase of 97.82%, yet the company continued to report a net loss of approximately 51.34 million CNY [9].

Core Viewpoint - The Hong Kong stock market is experiencing a surge in technology company listings, transforming into a global hub for tech capital, driven by a wave of domestic tech firms seeking to go public and the supportive role of the Hong Kong Stock Exchange [1][4][10]. Group 1: Technology Companies Listing Trend - A significant number of technology companies, including Black Sesame Intelligence, Horizon Robotics, and CATL, have either successfully listed or are preparing to list on the Hong Kong Stock Exchange [3][4]. - The trend of technology companies listing in Hong Kong is seen as both a short-term response to market conditions and a long-term strategic choice for firms aiming to expand their financing channels and international influence [4][10]. Group 2: Institutional Optimization - The surge in technology listings is attributed to continuous institutional optimizations by the Hong Kong Stock Exchange, which has created a more favorable environment for tech companies [6][7]. - Recent reforms, such as allowing dual-class shares and permitting unprofitable biotech firms to list, have attracted numerous mainland enterprises, aligning with the characteristics of high R&D investment and long profit cycles typical of tech firms [7][10]. Group 3: Positive Interaction Between Industry and Capital - The successful listing of CATL has boosted the confidence of other tech companies planning to go public, indicating that Hong Kong offers a more rational valuation platform for leading tech firms [9][10]. - The Hong Kong Stock Exchange's stringent financial disclosure and governance standards provide international recognition and enhance the trust and brand image of companies listed there [10].

股东询价转让结果报告书暨持股 5%以上股东权益变动 触及 1%的提示性公告 苏州纳芯壹号信息咨询合伙企业（有限合伙）、苏州纳芯贰号信息咨询合伙企 业（有限合伙）、苏州纳芯叁号信息咨询合伙企业（有限合伙）（以下合称"转让方"） 保证向苏州纳芯微电子股份有限公司（以下简称"纳芯微"或"公司"）提供的信息内 容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其真实性、准确性和完整 性依法承担法律责任。本公司及董事会全体成员保证公告内容与信息披露义务人提 供的信息一致。 重要内容提示: 本次询价转让的价格为163.15元/股，转让的股票数量为4,851,800股。 公司实际控制人控制的苏州纳芯壹号信息咨询合伙企业（有限合伙）、苏 州纳芯贰号信息咨询合伙企业（有限合伙）、苏州纳芯叁号信息咨询合伙 企业（有限合伙）参与本次询价转让。 本次权益变动为股份减持、被动稀释。本次转让不会导致公司控股股东、 实际控制人发生变化。 本次权益变动后，转让方苏州纳芯壹号信息咨询合伙企业（有限合伙）、 苏州纳芯贰号信息咨询合伙企业（有限合伙）、苏州纳芯叁号信息咨询合 伙企业（有限合伙）与一致行动人王升杨、盛云、王一峰、苏州瑞矽信 息咨询合 ...

上海证券交易所： 中信证券股份有限公司（以下简称"中信证券"或"组织券商"）受委托担任苏州 纳芯壹号信息咨询合伙企业（有限合伙）、苏州纳芯贰号信息咨询合伙企业（有限合伙）、 苏州纳芯叁号信息咨询合伙企业（有限合伙）（合称"转让方"）以向特定机构投资者询 价转让（以下简称"询价转让"）方式减持所持有的苏州纳芯微电子股份有限公司（以 下简称"公司"或"纳芯微"）首次公开发行前已发行股份的组织券商。 经核查，中信证券就本次询价转让的股东、受让方是否符合《上海证券交易所科创 板上市公司自律监管指引第 4 号——询价转让和配售》（以下简称"《询价转让和配售指 引》"）要求，本次询价转让的询价、转让过程与结果是否公平、公正，是否符合《询价 转让和配售指引》的规定作出如下报告说明。 一、本次询价转让概况 中信证券股份有限公司 关于苏州纳芯微电子股份有限公司 股东向特定机构投资者询价转让股份的核查报告 （一）本次询价转让转让方 截至 2025 年 5 月 20 日，转让方所持公司首发前股份的数量及占公司总股本比例情 况如下： | 序 | 股东名称 | 截至 2025 年 5 月 20 | 日 | 持股比例 | | --- | ...

"1+1"肯定大于2 公开信息显示，海光信息与中科曙光的合并涉及总市值高达4000亿元的半导体产业链重组。停牌之前， 中科曙光总市值约为905.7亿元，总股本14.63亿股，海光信息总股本3164亿元，总股本23.24亿股；股价 华夏时报（www.chinatimes.net.cn）记者 胡金华 上海报道 近期内地和香港资本市场热闹非凡，其中的主角当属半导体无疑！这边是内地半导体上市企业掀起赴港 融资潮，这边则是由科创板芯片企业海光信息（688041.SH）吸收合并主板半导体公司中科曙光 （603019.SH），正式拉开A股芯片半导体板块的重组大幕。 5月25日晚间，中科曙光和海光信息共同发布公告宣布，两家公司拟进行战略重组。若相关工作顺利推 进，将实现产业链相互补充，进一步促进信息产业龙头企业发展，对信息产业格局产生较大影响。公告 显示，二者正筹划由海光信息通过向中科曙光全体A股换股股东发行A股股票的方式换股吸收合并中科 曙光，并发行A股股票募集配套资金，两家股票将于5月26日起开始停牌，预计停牌时间不超过10个交 易日。 5月26日，有并购市场人士告诉《华夏时报》记者，海光信息合并中科曙光，简单理解是芯片 ...

Core Viewpoint - The global semiconductor industry is undergoing a rapid restructuring, with Hong Kong becoming a new hub for technology capital as leading semiconductor companies, including Weir Shares, plan to list on the Hong Kong Stock Exchange [2][3]. Group 1: Company Overview - Weir Shares, a leading CIS chip company, has announced its plan to issue H-shares and list on the Hong Kong Stock Exchange, with a market capitalization of nearly 160 billion yuan [2]. - The company aims to accelerate its international strategy and enhance its overseas financing capabilities, with plans to use the raised funds for technology development, market expansion, strategic investments, and general corporate purposes [3]. Group 2: Financial Performance - In 2024, Weir Shares is projected to achieve a revenue of 25.731 billion yuan, a year-on-year increase of 22.41%, with a net profit of 3.323 billion yuan, reflecting a significant increase of 498.11% [6]. - The company's overseas revenue accounted for 81.47% of total revenue, indicating a strong international market presence [6]. Group 3: Business Segments - The image sensor solutions segment is the primary revenue source for Weir Shares, generating 19.190 billion yuan in 2024, which constitutes 74.76% of its main business revenue, driven by growth in the smartphone and automotive markets [7]. - The touch and display solutions segment saw a revenue decline of 17.77%, while the analog solutions segment increased by 23.18% to 1.422 billion yuan [7]. Group 4: Strategic Developments - Weir Shares plans to change its name to OmniVision Integrated Circuits Group, Inc., to better reflect its industry positioning and future strategic direction [7][8]. - The acquisition of OmniVision Technologies in 2019 significantly boosted Weir Shares' performance, with the CMOS image sensor business becoming a core revenue driver, contributing 83.56% of revenue in 2019 [9].